Dongping Xu
100 Middle Street Of 4th Ring Road
Beijing, 100039, China
Beijing, 100039, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Hepatitis B virus rtCYE/rtCYEI mutations may contribute limited tenofovir resistance: Analysis of a large sample of Chinese patients.
Journal: World journal of hepatology
Published: March 31, 2025
Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model.
Journal: Frontiers in pharmacology
Published: August 11, 2021
Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs.
Journal: Antiviral research
Published: December 31, 2020
Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations.
Journal: World journal of gastroenterology
Published: April 23, 2020
Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients.
Journal: Journal of infection in developing countries
Published: March 10, 2020
Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients.
Journal: Antiviral research
Published: November 20, 2019
Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment.
Journal: Antiviral research
Published: April 27, 2019
On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B.
Journal: World journal of gastroenterology
Published: March 06, 2019
The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection.
Journal: Hepatology international
Published: November 23, 2017
Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: August 15, 2017
Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Journal: Antiviral research
Published: July 25, 2017
Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis.
Journal: Scientific reports
Published: March 03, 2017
Last Updated: 09/26/2026